Adagio Medical Holdings, Inc.
$1.53
▲
6.84%
2026-04-21 05:05:00
adagiomedical.com
NCM: ADGM
Explore Adagio Medical Holdings, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$34.43 M
Current Price
$1.53
52W High / Low
$2.87 / $0.74
Stock P/E
—
Book Value
$0.56
Dividend Yield
—
ROCE
-62.51%
ROE
-1.55%
Face Value
—
EPS
$-1.51
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
—
Beta
0.04
Debt / Equity
175.44
Current Ratio
2.44
Quick Ratio
2.24
Forward P/E
-1.21
Price / Sales
—
Enterprise Value
$33.08 M
EV / EBITDA
-1.58
EV / Revenue
—
Rating
Strong Buy
Target Price
$4
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Capital efficiency is modest.
- Leverage is relatively high.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Profusa, Inc. | $0.66 | — | $3.05 M | — | 8.32% | 8.05% | $957 / $0.41 | $-61.03 |
| 2. | iTonic Holdings Ltd. | $0.32 | — | $5.41 M | — | -59.82% | -71.25% | $32 / $0.25 | $0.36 |
| 3. | CVRx, Inc. | $7.24 | — | $193.65 M | — | -56.04% | -96.59% | $11.3 / $4.3 | $1.5 |
| 4. | Establishment Labs Holdings Inc. | $66.93 | — | $1.96 B | — | -14.18% | -1.33% | $83.31 / $28.67 | $0.8 |
| 5. | Bio-Rad Laboratories, Inc. | NOT FOUND | — | — | — | 2.17% | 10.84% | $343.12 / $211.43 | $276.16 |
| 6. | Masimo Corporation | $178.4 | 46.03 | $9.34 B | — | 23.57% | 23.43% | $179 / $125.94 | $13.84 |
| 7. | Glaukos Corporation | $123.8 | — | $7.27 B | — | -25.2% | -26.38% | $130.23 / $73.16 | $11.41 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | |
|---|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M | — |
| Operating Profit | -3.97 M | -5.72 M | -4.72 M | -7.4 M | — |
| Net Profit | -3.31 M | -10.12 M | -3.95 M | -7.71 M | — |
| EPS in Rs | -0.15 | -0.46 | -0.18 | -0.35 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0 M | — | 0.3 M | 0.19 M |
| Operating Profit | -21.89 M | — | -27.94 M | -23.91 M |
| Net Profit | -25.08 M | — | -38.15 M | -23.67 M |
| EPS in Rs | -1.13 | — | -1.72 | -1.07 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 43.25 M | 48.45 M | 6.83 M | 8.7 M |
| Total Liabilities | 30.85 M | 28.54 M | 138.85 M | 104.57 M |
| Equity | 12.4 M | 19.91 M | -132.02 M | -95.88 M |
| Current Assets | 20.08 M | 25.35 M | 5.18 M | 6.73 M |
| Current Liabilities | 8.23 M | 7.76 M | 47.18 M | 12.97 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Operating CF | -19.01 M | -25.65 M | -22.41 M | -19.31 M |
| Investing CF | -0.37 M | -0.34 M | -0.5 M | -1.27 M |
| Financing CF | 16.13 M | 21.88 M | 9.53 M | 0.13 M |
| Free CF | -19.39 M | -25.99 M | -22.91 M | -20.58 M |
| Capex | -0.37 M | -0.34 M | -0.5 M | -1.27 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | 58.73% | -30% | — |
| Earnings Growth % | — | -61.14% | -18.73% | — |
| Profit Margin % | — | -12715.33% | -12525.4% | -7384.44% |
| Operating Margin % | — | -9314% | -12652.38% | -7646.3% |
| Gross Margin % | — | -335.33% | -362.96% | -328.89% |
| EBITDA Margin % | — | -11985% | -12191.01% | -7260% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.